Highlight

SOFTWARE SYSTEMS 2006, June 22   Clinsight in the big leagues     Established in Gironde, the editor of management software for clinical trials known as Clinsight has just opened an office in Poitiers. Here is the portrait of a human-sized company on the rise. Mathieu Fourtillan is all smiles. Nearly eight years after having founded Clinsight on the shores of the Garonne river with the help of Yann Fleitour (*), the director of this small business has a lot to look forward to. Following a full year of intense negotiations, this editor of management software for clinical trials has just signed a substantial contract with the worldwide leader in animal health, the Merial group. “A superlative reference”, enthuses the young man from the Bordeaux area. It should be added that Clinsight nosed out Oracle Clinic and e-Trials, the “top two” of the market. The one-time pharmacy student - “I was meant to enter the pharmaceutical industry” - presently oversees a team (soon) composed of 14 persons to be found in Cenon, near Bordeaux, and in Poitiers, a second home base activated in 2005, which “draws the company closer to Parisian head offices”. “Before that, one of our commercial engineers was based in Paris, he wished to relocate in the French provinces. As for myself, I wanted to get closer to Paris. And so, we split the difference.” An international destiny While awaiting the construction of the Pâtis hotel for companies, this small concern is developing its activities in the Beaulieu area (4 persons). It should be mentioned that made by Clinsight “ready-made solutions” are not addressed to industry alone (Bayer animal health, Merial, Novartis animal health…). Clinical research organizations as well as cancerology research centers drive direct benefit from the company’s technologies. Canada, Switzerland, England, the United States, Spain… Clinsight unswervingly sets its sights on international markets. Moreover, “later on this year, we are likely to have colleagues in Spain and the United States. Our customers demand it”, carries on Mathieu Fourtillan who professes “not to regret the pharmaceutical industry”. I simply hope that ten years from now, we will still be around!” (*) Yann Fleitour is an IT engineer. http://www.clinsight.fr The Biopole en masse at Eurobio 2008 Read ...   Water information days (September 23 – September 25) Read ...   The rose and its genetic transformation Read ...   Christian Huyghe aims for “excellence” read...   Creating “medical branches” read...   A neuro-cardio-vascular pole is taking root read...   Valagro on the horticulture market read...   ERM, the winning spin-off read...   GMOs under debate in Poitiers read...   Isabelle Cameleyre, new representative read...   Cystic fibrosis: The molecule of hope read...   Irfaq, a manufacturer of innovations read...   CHU: State-of-the-art quality read...   Soil organic matter under examination read...   Parexel: The Cap provides its support read...   Philippe Michonneau: “The Biopole, fertile soil” read...   Painless monitoring of hepatitis read...   The Biopole structured as an association read...   Futuramat steps up the pace read...   Technova, or life in 3D read...   B Braun burnishes its image read...   Proteomics platform: The CHU strides ahead read...   The three missions of the University Botanical Garden read...   Clinsight in the big leagues read...   Natural energies for an autonomous building read...   Aster-Cephac turns into SGS Cephac read...   The previously unseen heart read...   BIOalternatives diversifies its markets read...   Two Poitiers-based projects awarded read...   IUT pores over biofuels read...   Poitiers, the biotechnology capital read...   PAREXEL wagers on the human factor read...   Saunier and associates wish to diversify read...   Biocydex and BioXtract move forward hand in hand read...   The grass of champions read...   Ianesco steadfastly believes in its future read...   A tumorotheque, what is the purpose it serves? read...   TechnAvOx has turned the corner read...   Larime is aiming for 40 beds in Poitiers read...   Poitiers is out to promote its research read...   A true Biopole milestone read...   A regional cancerology pole in the pipeline for 2007 read...   Nobel prize winners in Poitiers read...   A platform offering numerous advantages read...   @rtMolecule fashions in its own way read...   It’s plastic, it’s fantastic read...   The Poitiers hospital (CHU) stakes its claim read...   BIOalternatives exports its know-how read...   The physiological and computer science engineering program turns 30 read...   The Biopole takes center stage at Investiga read...           Legal mentions